Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Alnylam Pharmaceuticals (DUL.F) Q4 2023 Earnings
DUL.F
2
Nov
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.02
-0.8
0.42
1.64
Details
Expected EPS
-1.2433872000000001
Actual EPS
1.6390104
Surprise EPS
2.88
Surprise Percent
+231.82%
Description
Alnylam Pharmaceuticals (DUL.F) has reported earnings of 1.6390104 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login